MedTrace Logo

Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL

NCT05431868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2022-06-24

No results posted yet for this study

Summary

This prospective cohort study enrolled patients with implantation of a trifocal IOL. Only one eye of each patient was enrolled. Eyes were devided into three groups according the axial length (AL), including the short AL group, the control group and the long AL group. Manifest refraction, uncorrected and distance-corrected visual acuity at different distances, contrast sensitivity, aberrations and IOL decentration were measured three months after surgery. Spectacle independence, adverse photic phenomena, overall satisfaction and life quality were assessed with a questionnaire.

Conditions

  • Cataract
  • Presbyopia
  • Lenses, Intraocular
  • Myopia
  • Satisfaction

Interventions

OTHER

AT LISA tri 839MP (Carl Zeiss Meditec AG)

This prospective cohort study collected data of patients who underwent bilateral or unilateral cataract surgery with the AT LISA tri 839MP implantation.

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-01-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05431868 on ClinicalTrials.gov